New-onset interstitial lung disease can be detected up to 10 years after initial negative screening in patients with systemic sclerosis, with a higher mortality risk vs those without lung involvement.
The ATS/ERS 2025 statement on interstitial pneumonia classification updates the 2013 statement, with insights on secondary ...
Slower oxygen recovery after a 6-minute walk test may predict poorer lung function and a higher risk for disease progression in patients with fibrotic interstitial lung disease.
This trial marks the first time that automated, quantitative high-resolution CT (HRCT) imaging biomarkers will serve as a ...
A new study conducted by researchers at Queen Elizabeth Hospital Birmingham in Birmingham, Great Britain, evaluated outcomes and toxicity associated with stereotactic radiotherapy in patients with ...
Antifibrotic therapy shows similar efficacy in familial and sporadic IPF, with no significant differences in survival or acute exacerbations. Because familial idiopathic pulmonary fibrosis is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback